COVID 19 Memos
Categories
-
M&A Lessons from the COVID Crisis (February 3, 2021)
-
ISS Releases Guidance on Covid and Compensation (October 26, 2020)
-
Financial Reporting in Light of Covid-19: Statement from the SEC’s Office of the Chief Accountant (June 24, 2020)
-
Swiftly Accessing Capital Markets in Uncertain Times (June 4, 2020)
-
Corporate Governance Update: EESG and the Covid-19 Crisis (May 28, 2020)
-
Reopening to a New Normal: Considerations for Boards (May 18, 2020)
-
Update on Covid-19 Impacts on Landlords of Retail Debtors (May 18, 2020)
-
Creating Liquidity during the Covid-19 Pandemic: Convertible Bonds (May 13, 2020)
-
Top 10 Tax Issues in the Covid-19 Downturn (May 11, 2020)
-
Nasdaq Adopts Temporary Covid-19 Exception to Shareholder Approval Rules (May 8, 2020)
-
Managing Human Resources in a Challenging Economic Environment (May 7, 2020)
-
“New” IRS Guidance Provides Relief from Dividend Payment Requirement for REITs (May 6, 2020)
-
Lessons From the Future – The First Contested Virtual Annual Meeting (May 6, 2020)
-
REITs and Covid-19: 15 Key Issues for Boards as They Chart the Course Forward (April 28, 2020)
-
What to Say on Your Next Earnings Call in the Time of Covid-19: Providing Insights, Disclosing Scenarios and Managing Risks (April 20, 2020)
-
Covid-19 Impacts on Landlords of Retail Debtors (April 13, 2020)
-
Key ESG Considerations In the Crisis (April 13, 2020)
-
ISS Issues Guidance Regarding Covid-19 Pandemic (April 9, 2020)
-
Activist Attacks and Firm Value (April 9, 2020)
-
Federal Reserve Unveils Main Street Lending Program (April 9, 2020)
-
Delaware Court of Chancery Rejects Challenge to CEO Separation Agreement (April 8, 2020)
-
NYSE Temporarily Relaxes Shareholder Approval Rules (April 8, 2020)
-
What to Say on Your Next Earnings Call in the Time of Covid-19 – SEC Chairman Jay Clayton and CorpFin Director Bill Hinman Lead the Way (April 8, 2020)
-
White Collar and Regulatory Enforcement in the Era of Covid-19 (April 6, 2020)
-
REIT M&A and Activism: Preparing for Threats in the Covid-19 Environment (April 6, 2020)
-
Governance Litigation and the Covid-19 Pandemic (April 3, 2020)
-
Compensation Limits on Corporate Participants in CARES Act Programs (April 2, 2020)
-
Rights Plans (“Poison Pills”) in the Covid-19 Environment – “On the Shelf and Ready to Go”? (April 1, 2020)
-
Fiduciary Duties in Times of Financial Distress (April 1, 2020)
-
Emergency Changes to Australian Foreign Investment Laws Continue Global Trend of Extending Reviews of Transactions (April 1, 2020)
-
Activists Will Show Their True Colors in Covid-19 Pandemic (March 31, 2020)
-
The CARES Act: Litigation and Enforcement Lessons from the Financial Crisis (March 30, 2020)
-
Preserving Liquidity during the Covid-19 Pandemic (March 30, 2020)
-
The CARES Act Expands the Charitable Contribution Deduction (March 29, 2020)
-
Congress Passes CARES Act (March 27, 2020)
-
Merger Control in the Current Crisis (March 27, 2020)
-
Corporate Governance Update: Director Oversight in the Context of Covid-19 (March 26, 2020)
-
Disclosure in the Time of Covid-19 – Guidance from the Division of Corporation Finance (March 26, 2020)
-
Financial Institutions Developments – Stimulus Bill Authorizes FDIC Guarantee of Bank Debt and Unlimited Deposit Insurance of Transaction Accounts (March 26, 2020)
-
The Crisis and the Activist and Raiders (March 25, 2020)
-
Government Stimulus Funding: Planning Ahead by Looking Back (March 24, 2020)
-
Controlling Material, Non-Public Information During the Coronavirus Pandemic (March 24, 2020)
-
Litigation Priorities and the Crisis (March 23, 2020)
-
Disclosure Issues Relating to Covid-19 (March 20, 2020)
-
Debt Covenant Compliance and the Covid-19 Pandemic (March 20, 2020)
-
Regulators Around the World Address Short Selling in Response to the Covid-19 Market Crisis (March 19, 2020)
-
BlackRock Announces New KPIs for Public Companies, Tougher Director Votes and Continued High Expectations During Covid-19 Pandemic (March 18, 2020)
-
Covid-19: What Compensation Committees Should Be Thinking About Today (March 18, 2020)
-
Key Issues for Directors Relating to Covid-19 (March 17, 2020)
-
Corporate Liquidity and the Covid-19 Pandemic (March 17, 2020)